Nevirapine vs efavirenz in virologically supressed patients: differences in lipoprotein subclasses and inflammatory biomarkers.

MLA

Estrada, V., et al. “Nevirapine vs Efavirenz in Virologically Supressed Patients: Differences in Lipoprotein Subclasses and Inflammatory Biomarkers.” Journal of the International AIDS Society, vol. 15, Nov. 2012, p. 1. EBSCOhost, https://doi.org/10.7448/IAS.15.6.18151.

APA

Estrada, V., Gómez-Garre, M., Santos, J., Gutiérrez, F., Labarga, P., Palacios, R., Masiá, M., López-Vázquez, M., Isernia, V., Vispo, E., & Fernández-Cruz, A. (2012). Nevirapine vs efavirenz in virologically supressed patients: differences in lipoprotein subclasses and inflammatory biomarkers. Journal of the International AIDS Society, 15, 1. https://doi.org/10.7448/IAS.15.6.18151

Chicago

Estrada, V, M Gómez-Garre, J Santos, F Gutiérrez, P Labarga, R Palacios, M Masiá, et al. 2012. “Nevirapine vs Efavirenz in Virologically Supressed Patients: Differences in Lipoprotein Subclasses and Inflammatory Biomarkers.” Journal of the International AIDS Society 15 (November): 1. doi:10.7448/IAS.15.6.18151.